Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06928545 · ClinicalTrials.gov registry record
MagDI U.S. Registry
A clinical trial of Internal Hernia and Anastomosis, Surgical, sponsored by GT Metabolic Solutions.
- Recruiting
- Registry status
- 106
- Enrollment target
- 5
- Study locations
NCT06928545 is a study of Internal Hernia and Anastomosis, Surgical that is actively recruiting participants, run by GT Metabolic Solutions. The registered enrollment target is 106 participants. The trial reports 5 study locations across 5 states.
The verdict
NCT06928545, a study of Internal Hernia and Anastomosis, Surgical, is actively recruiting participants, sponsored by GT Metabolic Solutions.
- RECRUITING
- Registry status
- 106 participants
- Enrollment target
- 5
- Study locations
Study Summary
Assess the incidence and severity of internal hernia and bowel obstruction at one year in a U.S. population following use of the MagDI System to create side-to-side duodeno-ileal anastomoses.
Conditions Studied
Interventions
- DEVICE Side-to-side duodenal-ileal anastomosis
Study Locations (5)
California
- Ventura Advanced Surgical Associates - Ventura
Kentucky
- Baptist Healthcare System, Inc. - Louisville
Louisiana
- Ochsner Clinic Foundation - Lafayette
North Carolina
- Bariatric Specialists of the Carolinas - Cary
Washington
- Transform Weight Loss - Lynnwood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2025-03-28 |
| Est. Completion | 2027-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06928545
The ClinicalTrials.gov registry entry for NCT06928545 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GT Metabolic Solutions, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Internal Hernia appearing as the primary indexed condition, and to 1 intervention - of which Side-to-side duodenal-ileal anastomosis is the first listed.
NCT06928545 reports 5 study locations spanning 5 distinct geographic areas - top geographies include California, Kentucky, Louisiana.
Frequently Asked Questions
What is clinical trial NCT06928545 about?
NCT06928545 is a clinical study titled "MagDI U.S. Registry". Assess the incidence and severity of internal hernia and bowel obstruction at one year in a U.S. population following use of the MagDI System to create side-to-side duodeno-ileal anastomoses.
What is the current status of trial NCT06928545?
This trial is currently recruiting. The enrollment target is 106 participants. The study started on 2025-03-28. Estimated completion is 2027-04.
What conditions does trial NCT06928545 study?
This clinical trial studies the following conditions: Internal Hernia, Anastomosis, Surgical, Bowel Obstruction.
What interventions are being tested in trial NCT06928545?
The interventions under investigation include: Side-to-side duodenal-ileal anastomosis (DEVICE).
Who is sponsoring clinical trial NCT06928545?
This trial is sponsored by GT Metabolic Solutions, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06928545 being conducted?
This trial has 5 study locations across California, Kentucky, Louisiana, North Carolina, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Internal Hernia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.